Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors

Thesis (MSc)--Stellenbosch University, 2013.

Saved in:
Bibliographic Details
Main Author: Muller, Ronel
Other Authors: Pelly, Stephen C.
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2013
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613810492178432
access_status_str Open Access
author Muller, Ronel
author2 Pelly, Stephen C.
author_browse Muller, Ronel
Pelly, Stephen C.
author_facet Pelly, Stephen C.
Muller, Ronel
author_sort Muller, Ronel
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MSc)--Stellenbosch University, 2013.
format Thesis
id oai:scholar.sun.ac.za:10019.1/85686
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:42:03.173Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2013
publishDateRange 2013
publishDateSort 2013
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/85686 The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors Muller, Ronel Pelly, Stephen C. Van Otterlo, Willem A. L. Stellenbosch University. Faculty of Science. Dept. of Chemistry and Polymer Science. Reverse transcriptase -- Inhibitors HIV (Viruses) Dissertations -- Chemistry Theses -- Chemistry Chemistry and Polymer Science Thesis (MSc)--Stellenbosch University, 2013. ENGLISH ABSTRACT: With a cure for HIV and AIDS still absent, non-nucleoside reverse transcriptase inhibitors (NNRTIs) play a major role in the current antiretroviral treatments used, which have shown to improve and prolong the lives of HIV patients significantly. However, with rapid mutations of the HI virus, the use of these drugs is becoming limited, thereby highlighting the need for the development of new NNRTIs. Previous work by our research team has led to the development of a cyclopropyl-containing indole-based compound with an inhibition activity (IC50 value) of 0.1 μM, as determined in an in vitro single-cycle, non-replicative phenotypic assay. Therefore, in this project, we focussed on enhancing the intermolecular interactions of our compound to three major areas in the NNRTI binding pocket, namely the Tyr181, the Val179, and the Lys101 binding pockets. Hereby we were able to obtain both improved and lower potencies, with our most active compound having an inhibition activity (IC50 value) of 1 nM. For the interaction to the Tyr181 binding pocket, we were thus unable to synthesise a heterocyclic ring system onto our molecule as opposed to the previously used phenyl ring. Secondly, for the interaction to the Lys101 binding pocket we were able to synthesise a tetrazole ring system and an amide functionality onto the 2-position of the indole. Lastly, in our quest to synthesise the cyclopropyl moiety onto our compound for the interaction in the Val179 binding pocket, we were able to investigate the full inhibition effect of this interaction by synthesising a similar compound with no interaction in this binding pocket. Moreover, we were able to synthesise a new compound with a methoxy moiety for this interaction with an inhibition activity (IC50 value) of 1 nM. With this compound only being submitted for efficacy evaluation as a racemic compound mixture, this opened a new door for research possibilities for our team. AFRIKAANSE OPSOMMING: In die awesigheid van 'n geneesmiddel vir MIV en VIGS, speel nie-nukleosied omkeerbare transkripsie inhibitore ("NNRTIs")'n groot rol in die huidige antiretrovirale behandeling. Ongelukkig ondergaan die MI virus mutasies, wat dus die gebruik van hierdie antiretrovirale middels beperk. Hierdie beklemtoon dus die noodsaaklikheid vir die ontwikkeling van nuwe "NNRTIs". Vorige werk wat deur ons navorsings groep verrig is, het gelei tot die ontwikkeling van "n siklopropiel bevattende indol verbinding, met "n inhibisie aktiwiteit ("IC50" waarde) van 0.1 μM. Gevolglik, het ons in hierdie projek gefokus om die intermolekulêre interaksies van hierdie verbinding in drie hoof areas in die "NNRTI" bindings ruimte te verbeter, genaamd die Tyr181, die Val179, en die Lys101 bindings ruimtes. Hierdie projek het dus beide verbeterde en ook laer inhibisie aktiwiteits resultate gelewer, waar die mees aktiewe verbinding 'n inhibisie aktiwiteit ("IC50" waarde) van 1 nM behaal het. Vir die interaksie na die Tyr181 bindings ruimte, was ons dus onsuksesvol om 'n heteroaromatiese ring te sintetiseer as plaasvervanger vir die oorspronklike feniel ring. Tweedens, vir die interaksie na die Lys101 bindings ruimte, was ons in staat om 'n tetrazol ring en 'n amied funksionaliteit aan die 2-posisie van die indol te sintetiseer. In ons stryd om die siklopropiel ring aan ons verbinding te sintetiseer vir die interaksie in die Val179 bindings ruimte, was ons in staat om die volledige effek van hierdie interaksie te bepaal deur 'n soortgelykke verbinding te sintetiseer met geen interaksie in die Val179 bindings ruimte nie. Daarenbowe, het ons 'n verbining gesintetiseer met 'n inhibisie aktiwiet ("IC50" waarde) van 1 nM, waarvan die aktiwitiet van slegs die rasemiese mengsel van die verbinding bepaal is. Hierdie vinding het dus 'n nuwe navorsings deur vir ons groep geopen. 2013-11-22T10:59:15Z 2013-12-13T15:17:00Z 2013-11-22T10:59:15Z 2013-12-13T15:17:00Z 2013-12 Thesis http://hdl.handle.net/10019.1/85686 en_ZA Stellenbosch University xiv, 175 p. : ill. application/pdf application/pdf Stellenbosch : Stellenbosch University
spellingShingle Reverse transcriptase -- Inhibitors
HIV (Viruses)
Dissertations -- Chemistry
Theses -- Chemistry
Chemistry and Polymer Science
Muller, Ronel
The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
title The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
title_full The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
title_fullStr The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
title_full_unstemmed The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
title_short The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
title_sort rational design and synthesis of novel hiv non nucleoside reverse transcriptase inhibitors
topic Reverse transcriptase -- Inhibitors
HIV (Viruses)
Dissertations -- Chemistry
Theses -- Chemistry
Chemistry and Polymer Science
url http://hdl.handle.net/10019.1/85686
work_keys_str_mv AT mullerronel therationaldesignandsynthesisofnovelhivnonnucleosidereversetranscriptaseinhibitors
AT mullerronel rationaldesignandsynthesisofnovelhivnonnucleosidereversetranscriptaseinhibitors